Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Metabolic profiling of rat brain and cognitive behavioral tasks: potential complementary strategies in preclinical cognition enhancement research.

Goh DP, Neo AH, Goh CW, Aw CC, New LS, Chen WS, Atcha Z, Browne ER, Chan EC.

J Proteome Res. 2009 Dec;8(12):5679-90. doi: 10.1021/pr900795g.

PMID:
19845403
2.

Early postnatal maternal deprivation in rats induces memory deficits in adult life that can be reversed by donepezil and galantamine.

Benetti F, Mello PB, Bonini JS, Monteiro S, Cammarota M, Izquierdo I.

Int J Dev Neurosci. 2009 Feb;27(1):59-64. doi: 10.1016/j.ijdevneu.2008.09.200. Epub 2008 Oct 2.

PMID:
18948184
3.

Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.

Geerts H, Guillaumat PO, Grantham C, Bode W, Anciaux K, Sachak S.

Brain Res. 2005 Feb 8;1033(2):186-93.

PMID:
15694923
4.

Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35).

Tsunekawa H, Noda Y, Mouri A, Yoneda F, Nabeshima T.

Behav Brain Res. 2008 Jul 19;190(2):224-32. doi: 10.1016/j.bbr.2008.03.002. Epub 2008 Mar 18.

PMID:
18420288
5.

Effects of galantamine and donepezil on active and passive avoidance tests in rats with induced hypoxia.

Dimitrova DS, Getova-Spassova DP.

J Pharmacol Sci. 2006 Jul;101(3):199-204.

6.

Comparison of galantamine and donepezil for effects on nerve growth factor, cholinergic markers, and memory performance in aged rats.

Hernandez CM, Gearhart DA, Parikh V, Hohnadel EJ, Davis LW, Middlemore ML, Warsi SP, Waller JL, Terry AV Jr.

J Pharmacol Exp Ther. 2006 Feb;316(2):679-94. Epub 2005 Oct 7.

PMID:
16214877
7.

Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).

Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC.

J Proteome Res. 2009 Jan;8(1):352-61. doi: 10.1021/pr8006232.

PMID:
19063642
8.

Alternative method of oral dosing for rats.

Atcha Z, Rourke C, Neo AH, Goh CW, Lim JS, Aw CC, Browne ER, Pemberton DJ.

J Am Assoc Lab Anim Sci. 2010 May;49(3):335-43.

9.

Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis.

Zhang HY, Chen X, Hu P, Liang QL, Liang XP, Wang YM, Luo GA.

Talanta. 2009 Jul 15;79(2):254-9. doi: 10.1016/j.talanta.2009.03.045. Epub 2009 Mar 31.

PMID:
19559874
10.

Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.

Mega MS, Dinov ID, Porter V, Chow G, Reback E, Davoodi P, O'Connor SM, Carter MF, Amezcua H, Cummings JL.

Arch Neurol. 2005 May;62(5):721-8.

PMID:
15883258
11.

Chronic treatment of old rats with donepezil or galantamine: effects on memory, hippocampal plasticity and nicotinic receptors.

Barnes CA, Meltzer J, Houston F, Orr G, McGann K, Wenk GL.

Neuroscience. 2000;99(1):17-23.

PMID:
10924948
12.
13.

In vivo 1H-magnetic resonance spectroscopy can detect metabolic changes in APP/PS1 mice after donepezil treatment.

Westman E, Spenger C, Oberg J, Reyer H, Pahnke J, Wahlund LO.

BMC Neurosci. 2009 Apr 7;10:33. doi: 10.1186/1471-2202-10-33.

14.

Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.

Shearman E, Rossi S, Szasz B, Juranyi Z, Fallon S, Pomara N, Sershen H, Lajtha A.

Brain Res Bull. 2006 Mar 31;69(2):204-13. Epub 2005 Dec 21.

PMID:
16533671
15.

Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.

Caricati-Neto A, D'angelo LC, Reuter H, Hyppolito Jurkiewicz N, Garcia AG, Jurkiewicz A.

Eur J Pharmacol. 2004 Oct 25;503(1-3):191-201.

PMID:
15496314
16.

Acute cognitive effects of donepezil in young, healthy volunteers.

Zaninotto AL, Bueno OF, Pradella-Hallinan M, Tufik S, Rusted J, Stough C, Pompéia S.

Hum Psychopharmacol. 2009 Aug;24(6):453-64. doi: 10.1002/hup.1044.

PMID:
19637397
17.

Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.

Grayson B, Idris NF, Neill JC.

Behav Brain Res. 2007 Nov 22;184(1):31-8. Epub 2007 Jun 29.

PMID:
17675172
18.

Detailed analysis of the behavior of Lister and Wistar rats in anxiety, object recognition and object location tasks.

Ennaceur A, Michalikova S, Bradford A, Ahmed S.

Behav Brain Res. 2005 Apr 30;159(2):247-66. Epub 2004 Dec 8.

PMID:
15817188
19.

Galantamine-induced behavioral recovery after sublethal excitotoxic lesions to the rat medial septum.

Mulder J, Harkany T, Czollner K, Cremers TI, Keijser JN, Nyakas C, Luiten PG.

Behav Brain Res. 2005 Aug 30;163(1):33-41.

PMID:
15951032
20.

Preclinical research into cognition enhancers.

Sarter M.

Trends Pharmacol Sci. 2006 Nov;27(11):602-8. Epub 2006 Sep 25. Review.

PMID:
16997388

Supplemental Content

Support Center